Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the relative bioavailability of nicotine following single application of a new transdermal formulation to that of a reference formulation.

4 single 24hour applications separated by 48hour intervals.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT01658202
Study type Interventional
Source Pierre Fabre Medicament
Contact
Status Completed
Phase Phase 1
Start date August 2012
Completion date September 2012

See also
  Status Clinical Trial Phase
Withdrawn NCT00159302 - Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control
Completed NCT03728530 - Effect Of Deep Breathing Exercises In Smokers N/A
Completed NCT02089308 - Nicotine Patch - Bioequivalence Study Phase 1
Completed NCT01574898 - Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations Phase 1
Completed NCT01658215 - Nicotine Patch - Multidose Bioequivalence Study Phase 1
Terminated NCT00753870 - Range of Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers Phase 1
Completed NCT01188239 - A Structured Protocol to Evaluate Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette) Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette) N/A
Completed NCT01194583 - Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette) Without Nicotine Cartridges N/A
Completed NCT01164072 - Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette) N/A